Extended Data Fig. 3: Decrease in inflammatory biomarkers at long-term timepoints. | Nature Medicine

Extended Data Fig. 3: Decrease in inflammatory biomarkers at long-term timepoints.

From: BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

Extended Data Fig. 3

Analytes relevant to immune reset and autoimmune inflammation with significant decreases at month 12, including EN-RAGE, TRAIL, TNFSF14, and TGF-β1 (placebo – month 3: n = 10; DC-08 – month 1: n = 11, month 3: n = 11, month 6: n = 6, month 12: n = 7). Source data are provided for this figure.

Source data

Back to article page